Venture Capital & Emerging Companies
Viewpoints
Filter by:
SPAC Chat Ep. 5: Tempering the SPAC Hype
June 4, 2021 | Podcast | By Thomas Burton, Jeffrey Schultz, Sahir Surmeli
Please join your favorite SPAC corporate attorneys, Tom Burton, Sahir Surmeli, and Jeff Schultz as they set the record straight on SPACs’ apparent boom and bust, heavily reported on in the media.
Read more
SPAC Chat Ep. 4: Litigation Update: Preparing for the Next Wave of Suits Against SPACs
April 27, 2021 | Podcast | By Jeffrey Schultz, Sahir Surmeli
It seems that everyone is taking a second look at SPACs as the number of lawsuits against these alternative IPOs continues to increase by the day.
Read more
SPAC Chat Ep. 3: Tracking Trends of the SPAC Surge
March 29, 2021 | Podcast | By Thomas Burton, Jeffrey Schultz, Sahir Surmeli
There is no denying the surge in special purpose acquisition companies (SPACs) and that these financing vehicles have had a significant impact on financial markets.
Read more
SPAC Chat Ep. 2: The Controversy Over Sponsor Equity
March 9, 2021 | Podcast | By Thomas Burton, Jeffrey Schultz, Sahir Surmeli
Does a minimal investment in a Special Purpose Acquisition Company (SPAC) entitle a sponsor to a tremendous amount of equity after a successful IPO?
Read more
SPAC Chat: Busting Common Myths about SPACs
February 9, 2021 | Podcast | By Thomas Burton, Jeffrey Schultz, Sahir Surmeli
Special Purpose Acquisition Companies (SPACs) are taking over Wall Street as more and more companies are taking advantage of this alternative IPO strategy.
Read more
Explore Other Viewpoints:
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Cross-Border Asset Recovery
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment
- Energy & Sustainability
- Environmental Enforcement Defense
- Environmental Law
- FDA Regulatory
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Pharmacy Benefits and PBM Contracting
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology